Literature DB >> 27872267

Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman's Dynamic Legacy.

David L Braff1, Carol A Tamminga2.   

Abstract

First, we describe the hallmark contributions of Irv Gottesman's pioneering scholarship for schizophrenia research including concepts of polygenicity, gene × environment interactions, epigenetics and the endophenotype concept. Gottesman and colleagues' twin studies showed that genes, not social factors, mediate schizophrenia risk. He then showed that schizophrenia is highly polygenic. Next, he introduced the concept of epigenetics into schizophrenia research. Gottesman then introduced the quantitative endophenotype concept. Endophenotypes are laboratory-based measures that show deficits in schizophrenia patients and lesser deficits in their first degree "unaffected" relatives and are viewed as being more proximal to genes and having a simpler genetic architecture than are "fuzzy" qualitative diagnostic disorders. Endophenotypes offer an exciting path to gene discovery, neural circuits, genetic architecture and new treatment pathways of schizophrenia and related psychotic disorders. Second, we were asked to discuss 2 of many endophenotype Consortia and related studies, in order to illustrate the impact of Gottesman's work. We describe the Consortium on the Genetics of Schizophrenia (COGS) exploring neurocognitive and neurophysiological endophenotypes in family and case-control studies. Association, linkage, sequencing and epigenetic studies are described. The Bipolar and Schizophrenia Network for Intermediate Phenotypes (BSNIP) uses an array of endophenotypes including brain imaging in studies across the psychosis dimension, allowing for dimensional analyses. BSNIP results have led to the concept of biotypes, advancing the field. Irv Gottesman was imaginatively prescient in generating novel insights and predicting many major issues which challenge schizophrenia researchers who still use his concepts to guide current research approaches.
© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Gottesman; biomarkers; endophenotypes; genes; schizophrenia

Mesh:

Year:  2016        PMID: 27872267      PMCID: PMC5216869          DOI: 10.1093/schbul/sbw157

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  35 in total

1.  Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia.

Authors:  Raquel E Gur; Vishwajit L Nimgaonkar; Laura Almasy; Monica E Calkins; J Daniel Ragland; Michael F Pogue-Geile; Stephen Kanes; John Blangero; Ruben C Gur
Journal:  Am J Psychiatry       Date:  2007-05       Impact factor: 18.112

2.  Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults.

Authors:  Karolina A Aberg; Joseph L McClay; Srilaxmi Nerella; Shaunna Clark; Gaurav Kumar; Wenan Chen; Amit N Khachane; Linying Xie; Alexandra Hudson; Guimin Gao; Aki Harada; Christina M Hultman; Patrick F Sullivan; Patrik K E Magnusson; Edwin J C G van den Oord
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

3.  Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study.

Authors:  Rebekka Lencer; Andreas Sprenger; James L Reilly; Jennifer E McDowell; Leah H Rubin; Judith A Badner; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; Brett A Clementz; John A Sweeney
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

4.  California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS).

Authors:  William S Stone; Raquelle I Mesholam-Gately; David L Braff; Monica E Calkins; Robert Freedman; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Larry J Siever; Jeremy M Silverman; Joyce Sprock; Catherine A Sugar; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Larry J Seidman
Journal:  Schizophr Res       Date:  2014-12-12       Impact factor: 4.939

5.  Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.

Authors:  W C Hochberger; S K Hill; C L M Nelson; J L Reilly; R S E Keefe; G D Pearlson; M S Keshavan; C A Tamminga; B A Clementz; J A Sweeney
Journal:  Schizophr Res       Date:  2015-11-30       Impact factor: 4.939

Review 6.  The neuropsychiatric translational revolution: still very early and still very challenging.

Authors:  Lara Braff; David L Braff
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

7.  Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

Authors:  A E Farmer; P McGuffin; I I Gottesman
Journal:  Arch Gen Psychiatry       Date:  1987-07

8.  Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).

Authors:  Carol A Tamminga; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Bradley Witte; David W Morris; Jeffrey Bishop; Gunvant K Thaker; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

9.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

10.  An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation.

Authors:  Eilis Hannon; Emma Dempster; Joana Viana; Joe Burrage; Adam R Smith; Ruby Macdonald; David St Clair; Colette Mustard; Gerome Breen; Sebastian Therman; Jaakko Kaprio; Timothea Toulopoulou; Hilleke E Hulshoff Pol; Marc M Bohlken; Rene S Kahn; Igor Nenadic; Christina M Hultman; Robin M Murray; David A Collier; Nick Bass; Hugh Gurling; Andrew McQuillin; Leonard Schalkwyk; Jonathan Mill
Journal:  Genome Biol       Date:  2016-08-30       Impact factor: 13.583

View more
  2 in total

1.  Error-related brain activity as a transdiagnostic endophenotype for obsessive-compulsive disorder, anxiety and substance use disorder.

Authors:  Anja Riesel; Julia Klawohn; Rosa Grützmann; Christian Kaufmann; Stephan Heinzel; Katharina Bey; Leonhard Lennertz; Michael Wagner; Norbert Kathmann
Journal:  Psychol Med       Date:  2019-02-12       Impact factor: 7.723

2.  A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains.

Authors:  Siri Ranlund; Stella Calafato; Johan H Thygesen; Kuang Lin; Wiepke Cahn; Benedicto Crespo-Facorro; Sonja M C de Zwarte; Álvaro Díez; Marta Di Forti; Conrad Iyegbe; Assen Jablensky; Rebecca Jones; Mei-Hua Hall; Rene Kahn; Luba Kalaydjieva; Eugenia Kravariti; Colm McDonald; Andrew M McIntosh; Andrew McQuillin; Marco Picchioni; Diana P Prata; Dan Rujescu; Katja Schulze; Madiha Shaikh; Timothea Toulopoulou; Neeltje van Haren; Jim van Os; Evangelos Vassos; Muriel Walshe; Cathryn Lewis; Robin M Murray; John Powell; Elvira Bramon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-08-29       Impact factor: 3.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.